UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 2, 2010

OR

o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 1-5129

MOOG inc.

(Exact name of registrant as specified in its charter)

New York State		16-0757636
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
East Aurora, New York		14052-0018
(Address of principal executive offices)		(Zip Code)

Telephone number including area code: (716) 652-2000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ		Accelerated filer o		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

The number of shares outstanding of each class of common stock as of February 4, 2010 was:

Class A common stock, $1.00 par value 41,230,317 shares

Class B common stock, $1.00 par value 4,143,661 shares

 

 

MOOG inc.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS

		PAGE
PART 1 FINANCIAL INFORMATION
Item 1 Financial Statements:
Consolidated Condensed Balance Sheets January 2, 2010 and October 3, 2009			3
Consolidated Condensed Statements of Earnings Three Months Ended January 2, 2010 and December 27, 2008			4
Consolidated Condensed Statements of Cash Flows Three Months Ended January 2, 2010 and December 27, 2008			5
Notes to Consolidated Condensed Financial Statements			6-17
Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations			18-31
Item 3 Quantitative and Qualitative Disclosures about Market Risk			31
Item 4 Controls and Procedures			31
PART II OTHER INFORMATION
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds			31
Item 6 Exhibits			32
SIGNATURES			33
EX-31.1
EX-31.2
EX-32.1

PART I FINANCIAL INFORMATION

Item 1. Financial Statements.

MOOG inc.

		January 2,				October 3,
(dollars in thousands)		2010				2009
ASSETS
CURRENT ASSETS
Cash and cash equivalents		$	101,301			$	81,493
Receivables			523,265				547,571
Inventories			465,691				484,261
Other current assets			102,000				97,073
TOTAL CURRENT ASSETS			1,192,257				1,210,398
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of $456,873 and $445,426, respectively			477,823				481,726
GOODWILL			694,454				698,459
INTANGIBLE ASSETS, net			215,627				220,311
OTHER ASSETS			19,545				23,423
TOTAL ASSETS		$	2,599,706			$	2,634,317
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Notes payable		$	16,460			$	16,971
Current installments of long-term debt			1,458				1,541
Accounts payable			114,078				125,257
Customer advances			57,109				66,811
Contract loss reserves			43,850				50,190
Other accrued liabilities			182,657				185,491
TOTAL CURRENT LIABILITIES			415,612				446,261
LONG-TERM DEBT, excluding current installments
Senior debt			409,588				435,944
Senior subordinated notes			378,626				378,630
LONG-TERM PENSION AND RETIREMENT OBLIGATIONS			222,033				225,747
DEFERRED INCOME TAXES			77,953				76,910
OTHER LONG-TERM LIABILITIES			5,036				5,792
TOTAL LIABILITIES			1,508,848				1,569,284
SHAREHOLDERS’ EQUITY
Common stock			51,280				51,280
Other shareholders’ equity			1,039,578				1,013,753
TOTAL SHAREHOLDERS’ EQUITY			1,090,858				1,065,033
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	2,599,706			$	2,634,317

See accompanying Notes to Consolidated Condensed Financial Statements.

MOOG inc.

		Three Months Ended
		January 2,				December 27,
(dollars in thousands, except per share data)		2010				2008
NET SALES		$	495,178			$	446,088
COST OF SALES			350,776				308,240
GROSS PROFIT			144,402				137,848
Research and development			23,882				25,130
Selling, general and administrative			78,127				69,199
Restructuring			1,819				—
Interest			10,728				9,601
Equity in earnings of LTi and other			394				(2,455	)
EARNINGS BEFORE INCOME TAXES			29,452				36,373
INCOME TAXES			7,891				6,103
NET EARNINGS		$	21,561			$	30,270
NET EARNINGS PER SHARE
Basic		$	0.48			$	0.71
Diluted		$	0.47			$	0.70
AVERAGE COMMON SHARES OUTSTANDING
Basic			45,323,349				42,607,289
Diluted			45,592,874				42,986,088

See accompanying Notes to Consolidated Condensed Financial Statements.

MOOG inc.

		Three Months Ended
		January 2,				December 27,
(dollars in thousands)		2010				2008
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings		$	21,561			$	30,270
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation			15,051				13,135
Amortization			7,551				3,830
Provisions for non-cash losses on contracts, inventories and receivables			7,550				12,814
Equity-based compensation expense			2,784				2,589
Other			(1,913	)			(3,264	)
Changes in assets and liabilities providing cash, excluding the effects of acquisitions:
Receivables			23,093				25,974
Inventories			14,720				(23,966	)
Accounts payable			(11,123	)			22
Customer advances			(9,647	)			1,068
Accrued expenses			(15,778	)			(26,200	)
Accrued income taxes			3,851				3,261
Other assets and liabilities			(1,635	)			(6,984	)
NET CASH PROVIDED BY OPERATING ACTIVITIES			56,065				32,549
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisitions of businesses, net of acquired cash			(358	)			(14,023	)
Purchase of property, plant and equipment			(11,628	)			(20,498	)
Other			4				29
NET CASH USED BY INVESTING ACTIVITIES			(11,982	)			(34,492	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net (repayments of) proceeds from notes payable			(279	)			4,434
Net (repayments of) proceeds from revolving lines of credit			(22,968	)			37,500
Payments on long-term debt			(1,747	)			(287	)
Excess tax benefits from equity-based payment arrangements			11				43
Other			1,153				(5,592	)
NET CASH (USED) PROVIDED BY FINANCING ACTIVITIES			(23,830	)			36,098
Effect of exchange rate changes on cash			(445	)			(2,552	)
INCREASE IN CASH AND CASH EQUIVALENTS			19,808				31,603
Cash and cash equivalents at beginning of period			81,493				86,814
CASH AND CASH EQUIVALENTS AT END OF PERIOD		$	101,301			$	118,417
CASH PAID FOR:
Interest		$	10,678			$	10,657
Income taxes, net of refunds			3,669				4,012

See accompanying Notes to Consolidated Condensed Financial Statements.

MOOG inc.

Note 1 — Basis of Presentation

The accompanying unaudited consolidated condensed financial statements have been prepared by management in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting of normal recurring adjustments considered necessary for the fair presentation of results for the interim period have been included. The results of operations for the three months ended January 2, 2010 are not necessarily indicative of the results expected for the full year. The accompanying unaudited consolidated condensed financial statements should be read in conjunction with the financial statements and notes thereto included in our Form 10-K for the fiscal year ended October 3, 2009. All references to years in these financial statements are to fiscal years.

Note 2 — Acquisitions

All of our acquisitions are accounted for under the purchase method and, accordingly, the operating results for the acquired companies are included in the consolidated statements of earnings from the respective dates of acquisition. Under purchase accounting, we record assets and liabilities at fair value on the balance sheet. All of the following acquisitions, with the exception of LTi REEnergy GmbH, resulted in goodwill being recorded as a result of the respective purchase price allocations.

On September 25, 2009, we acquired the flight control actuation business of GE Aviation Systems, with operations in Wolverhampton, U.K. The purchase price, net of cash acquired, was $90,786, which was initially financed with funds available under our revolving credit facility. The Wolverhampton flight controls business designs and manufactures primary and secondary flight control actuation for a number of commercial and military programs, including high-lift actuation systems for the Boeing 777 and 787 and the Airbus A330 and A380. Sales for the 2008 calendar year were approximately $100,000. This acquisition is included in our Aircraft Controls segment.

On June 4, 2008, we acquired a 40% ownership in LTi REEnergy GmbH, with operations in Germany and China, for cash of $28,288. LTi REEnergy specializes in the design and manufacture of servo controllers as well as complete drive systems for electric rotor blade controls for wind turbines. We accounted for this investment using the equity method of accounting with our net investment reflected in other assets on the balance sheet. On June 1, 2009, we acquired the remaining 60% of LTi REEnergy and began to consolidate 100% of the operating results from that date forward. The total purchase price, net of cash acquired, was $72,022. We financed the purchase price with available cash on hand of $12,834, issuance of a $13,451 unsecured note due to the seller in February 2010, $17,449 of assumed debt and the $28,288 cash paid for the 40% investment in 2008. Sales for the twelve months preceding the acquisition of the remaining 60% ownership were approximately $140,000. This acquisition is included in our Industrial Systems segment.

On March 2, 2009, we acquired Fernau Avionics Limited, a UK-based company. The purchase price, net of cash acquired, was $45,787, which was financed with credit facility borrowings. Fernau Avionics is a leading supplier of ground-based air navigation systems for military, naval and civil aviation. This acquisition complements our present navigation aids business in the U.S. Sales for the 2008 calendar year were approximately $22,500. This acquisition is included in our Aircraft Controls segment.

On February 13, 2009, we acquired Videolarm Inc., based in Decatur, Georgia. The purchase price, net of cash acquired, was $44,853, which was financed with credit facility borrowings. Videolarm produces products for surveillance systems including integrated cameras, vandal resistant protective housings and networked solutions. Sales for the 2008 calendar year were approximately $19,500. This acquisition is included in our Space and Defense Controls segment.

On January 30, 2009, we acquired 70% of the stock of Insensys Ltd., a UK-based company. On April 30, 2009, we acquired the remaining 30%. The purchase price, net of cash acquired, was $23,558 and was financed with available cash on hand. Insensys is a supplier of pitch control and rotor blade monitoring systems for wind turbines. Sales for the 2008 calendar year were approximately $8,000. This acquisition is included in our Industrial Systems segment.

On January 23, 2009, we acquired Ethox International, based in Buffalo, New York. The purchase price, net of cash acquired, was $15,131, which was financed with credit facility borrowings plus $6,814 of assumed debt. Ethox produces proprietary medical devices and is engaged in contract manufacturing of disposables for medical device companies. Ethox also provides microbiology, toxicology and sterilization services. Sales for the 2008 calendar year were approximately $27,000. This acquisition is included in our Medical Devices segment.

On December 30, 2008, we acquired Aitecs Medical UAB, a Lithuanian-based manufacturer of syringe-style infusion therapy pumps. The purchase price, net of cash acquired, was $21,379, which was financed with credit facility borrowings. Aitecs has a product portfolio that includes pumps for general hospital use, operating rooms and patient controlled analgesia. Sales for the twelve months preceding the acquisition were approximately $9,000. This acquisition is included in our Medical Devices segment.

On October 8, 2008, we acquired Berkeley Process Control, Inc., based in Richmond, California. The purchase price, net of cash acquired, was $14,036, which was financed with credit facility borrowings. Berkeley manufactures motion control software and hardware that automates the precise handling of semiconductor wafers and enhances the speed, quality and safety of welding in the oil and gas market and in nuclear fuel canisters. Sales for the twelve months preceding the acquisition were approximately $6,300. This acquisition is included in our Industrial Systems segment.

Our purchase price allocations are substantially complete with the exception of the Wolverhampton flight controls business and LTi REEnergy. Wolverhampton’s purchase price allocation is based on preliminary estimates of fair values of assets acquired and liabilities assumed. LTi REEnergy’s purchase price allocation is substantially complete with the exception of other current liabilities.

Note 3 — Inventories

		January 2,				October 3,
		2010				2009
Raw materials and purchased parts		$	202,511			$	206,414
Work in progress			203,512				214,021
Finished goods			59,668				63,826
Total		$	465,691			$	484,261

Note 4 — Goodwill and Intangible Assets

The changes in the carrying amount of goodwill for the three months ended January 2, 2010 are as follows:

		Balance as of				Adjustment				Foreign				Balance as of
		October 3,				To Prior Year				Currency				January 2,
		2009				Acquisitions				Translation				2010
Aircraft Controls		$	180,694			$	(4,165	)		$	359			$	176,888
Space and Defense Controls			106,802				—				—				106,802
Industrial Systems			124,155				—				(689	)			123,466
Components			159,359				—				712				160,071
Medical Devices			127,449				—				(222	)			127,227
Total		$	698,459			$	(4,165	)		$	160			$	694,454

The components of acquired intangible assets are as follows:

						January 2, 2010								October 3, 2009
		Weighted				Gross								Gross
		Average				Carrying				Accumulated				Carrying				Accumulated
		Life (years)				Amount				Amortization				Amount				Amortization
Customer-related			10			$	141,707			$	(38,418	)		$	142,555			$	(34,748	)
Program-related			18				64,123				(2,473	)			61,599				(1,475	)
Technology-related			9				50,739				(17,417	)			50,698				(15,955	)
Marketing-related			9				22,668				(10,678	)			22,616				(10,109	)
Contract-related			3				3,312				(276	)			3,000				—
Artistic-related			10				25				(20	)			25				(20	)
Acquired intangible assets			11			$	282,574			$	(69,282	)		$	280,493			$	(62,307	)

All acquired intangible assets other than goodwill are being amortized. Customer-related intangible assets primarily consist of customer relationships. Program-related intangible assets consist of long-term programs. Technology-related intangible assets primarily consist of technology, patents, intellectual property and engineering drawings. Marketing-related intangible assets primarily consist of trademarks, trade names and non-compete agreements. Contract-related intangible assets consist of favorable operating lease terms.

Amortization of acquired intangible assets was $7,108 for the three months ended January 2, 2010 and $3,441 for the three months ended December 27, 2008. Based on acquired intangible assets recorded at January 2, 2010, amortization is expected to be $27,770 in 2010, $26,472 in 2011, $25,556 in 2012, $21,914 in 2013 and $19,724 in 2014.

Note 5 — Product Warranties

In the ordinary course of business, we warrant our products against defects in design, materials and workmanship typically over periods ranging from twelve to thirty-six months. We determine warranty reserves needed by product line based on historical experience and current facts and circumstances. Activity in the warranty accrual is summarized as follows:

		Three Months Ended
		January 2,				December 27,
		2010				2008
Warranty accrual at beginning of period		$	14,675			$	10,015
Additions from acquisitions			—				83
Warranties issued during current period			1,734				1,927
Adjustments to pre-existing warranties			(98	)			649
Reductions for settling warranties			(2,512	)			(1,531	)
Foreign currency translation			(50	)			(239	)
Warranty accrual at end of period		$	13,749			$	10,904

Note 6 — Derivative Financial Instruments

We principally use derivative financial instruments to manage interest rate risk associated with long-term debt and foreign exchange risk related to foreign operations and foreign currency transactions. We enter into derivative financial instruments with a number of major financial institutions to minimize counterparty credit risk.

Derivatives designated as hedging instruments

Interest rate swaps are used to adjust the proportion of total debt that is subject to variable and fixed interest rates. The interest rate swaps are designated as hedges of the amount of future cash flows related to interest payments on variable-rate debt that, in combination with the interest payments on the debt, convert a portion of the variable-rate debt to fixed-rate debt. At January 2, 2010, we had interest rate swaps with notional amounts totaling $65,000. The interest rate swaps effectively convert this amount of variable-rate debt to fixed-rate debt at 3.8%, including the applicable margin of 225 basis points as of January 2, 2010. The interest will revert back to variable rates based on LIBOR plus the applicable margin upon their maturities in 2012.

We use foreign currency forward contracts as cash flow hedges to effectively fix the exchange rates on future payments and, to a much lesser extent, receipts. To mitigate exposure in movements between various currencies, primarily the British pound, Philippine peso and euro, we had outstanding foreign currency forwards with notional amounts of $30,368 at January 2, 2010. These contracts mature at various times through the second quarter of 2011.

These interest rate swaps and foreign currency forwards are recorded in the consolidated balance sheet at fair value and the related gains or losses are deferred in shareholders’ equity as a component of Accumulated Other Comprehensive Income (Loss) (AOCI). These deferred gains and losses are reclassified into expense during the periods in which the related payments or receipts affect earnings. However, to the extent the interest rate swaps and foreign currency forwards are not perfectly effective in offsetting the change in the value of the payments being hedged, the ineffective portion of these contracts is recognized in earnings immediately. Ineffectiveness was not material in 2010 or 2009.

Activity in Accumulated Other Comprehensive Income (Loss) (AOCI) related to these derivatives during the first three months of 2010 is summarized below:

		Pre-tax				Income				After-Tax
		Amount				Tax				Amount
Balance at October 3, 2009		$	(262	)		$	73			$	(189	)
Net decrease in fair value of derivatives			1,283				(401	)			882
Net reclassification from AOCI into earnings			(132	)			16				(116	)
Accumulated gain at January 2, 2010		$	889			$	(312	)		$	577

Activity and classification of derivatives for the three months ended January 2, 2010 are as follows:

		Classification of net gain				Net reclassification from				Net deferral in AOCI of
		(loss) recognized in				AOCI into earnings				derivatives
		earnings				(effective portion)				(effective portion)
Interest rate swaps		Interest expense				$	(327	)		$	161
Foreign currency forwards		Cost of sales					459				1,122
Net gain						$	132			$	1,283

Derivatives not designated as hedging instruments

We also have foreign currency exposure on intercompany balances that are denominated in a foreign currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in the statement of earnings. To minimize foreign currency exposure, we had foreign currency forwards with notional amounts of $118,872 at January 2, 2010. The foreign currency forwards are recorded in the balance sheet at fair value and resulting gains or losses are recorded in the statements of earnings. We recorded a net loss of $2,572 for the three months ended January 2, 2010 on the foreign currency forwards which are included in other income or expense and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances.

Summary of derivatives

The fair value and classification of derivatives on the consolidated balance sheet as of January 2, 2010 is summarized as follows:

		Other								Other				Other
		current				Other				accrued				long-term
		assets				assets				liabilities				liabilities
Derivatives designated as hedging instruments:
Foreign currency forwards		$	640			$	15			$	77			$	75
Interest rate swaps			95				60				33				—
		$	735			$	75			$	110			$	75
Derivatives not designated as hedging instruments:
Foreign currency forwards		$	2,284			$	—			$	1,506			$	—

Note 7 — Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate fair value. The definition of the fair value hierarchy is as follows:

Level 1 — Quoted prices in active markets for identical assets and liabilities.

Level 2 — Observable inputs other than quoted prices in active markets for similar assets and liabilities.

Level 3 — Inputs for which significant valuation assumptions are unobservable in a market and therefore value is based on the best available data, some of which is internally developed and considers risk premiums that a market participant would require.

The following table presents the fair values and classification of our financial assets and liabilities measured on a recurring basis as of January 2, 2010:

		Classification		Level 1				Level 2				Level 3				Total
Foreign currency forwards		Other current assets		$	—			$	2,924			$	—			$	2,924
Foreign currency forwards		Other assets			—				15				—				15
Foreign currency forwards		Other accrued liabilities			—				(1,583	)			—				(1,583	)
Foreign currency forwards		Other long-term liabilities			—				(75	)			—				(75	)
Interest rate swaps		Other current assets			—				95				—				95
Interest rate swaps		Other assets			—				60				—				60
Interest rate swaps		Other accrued liabilities			—				(33	)			—				(33	)
Net fair value				$	—			$	1,403			$	—			$	1,403

Our only financial instrument for which the carrying value at times differs from its fair value is long-term debt. At January 2, 2010, the fair value of long-term debt was $773,577 compared to its carrying value of $789,672. The fair value of long-term debt was estimated based on quoted market prices.

Note 8 — Restructuring

We have initiated restructuring plans to better align our cost structure with lower sales activity associated with the global recession. The restructuring actions taken have or will result in workforce reductions, primarily in the U.S., the Philippines and Europe.

Restructuring expense by segment for the three months ended January 2, 2010 is as follows:

		Severance
Aircraft Controls		$	1,192
Industrial Systems			394
Components			239
Medical Devices			(6	)
Total		$	1,819

Restructuring expense related to these actions was $15,067 in 2009. We anticipate additional amounts in 2010, primarily in Aircraft Controls and Industrial Systems. Payments related to these severance benefits are expected to be paid in full by the end of 2010. We are continuing to evaluate additional restructuring plans.

Restructuring activity for the quarter ended January 2, 2010 is as follows:

		Severance
Balance at beginning of period		$	14,332
Charged to expense			2,062
Adjustments for prior accruals			(243	)
Cash payments			(2,088	)
Foreign currency translation			(122	)
Balance at end of period		$	13,941

Note 9 — Employee Benefit Plans

Net periodic benefit costs for U.S. pension plans consist of:

		Three Months Ended
		January 2,				December 27,
		2010				2008
Service cost		$	4,680			$	3,494
Interest cost			6,767				6,382
Expected return on plan assets			(8,836	)			(7,981	)
Amortization of prior service cost			50				74
Amortization of actuarial loss			1,237				211
Pension expense for defined benefit plans			3,898				2,180
Pension expense for defined contribution plans			1,728				1,354
Total pension expense for U.S. plans		$	5,626			$	3,534
Net periodic benefit costs for non-U.S. pension plans consist of:
		Three Months Ended
		January 2,				December 27,
		2010				2008
Service cost		$	818			$	885
Interest cost			1,563				1,425
Expected return on plan assets			(944	)			(871	)
Amortization of prior service credit			(14	)			(12	)
Amortization of actuarial loss			133				118
Pension expense for defined benefit plans			1,556				1,545
Pension expense for defined contribution plans			1,430				412
Total pension expense for non-U.S. plans		$	2,986			$	1,957

During the three months ended January 2, 2010, we made contributions to our defined benefit pension plans of $6,000 to the U.S. plans and $1,032 to the non-U.S. plans. We anticipate contributing an additional $18,125 to the U.S. plans and $3,145 to the non-U.S. plans for a total of $28,302 in 2010.

Net periodic benefit costs for the post-retirement health care benefit plan consist of:

		Three Months Ended
		January 2,				December 27,
		2010				2008
Service cost		$	143			$	104
Interest cost			336				341
Amortization of transition obligation			99				99
Amortization of prior service cost			54				67
Amortization of actuarial loss			210				96
Total periodic post-retirement benefit cost		$	842			$	707

Note 10 — Income Taxes

The effective tax rate for the first quarter of 2010 is lower than would be expected by applying the U.S. federal statutory tax rate to earnings before income taxes as a greater proportion of earnings came from foreign operations with lower tax rates. During the first quarter of 2009, our effective tax rate reflected our decision to repatriate approximately $31,000 of cash to the U.S. from our Japanese subsidiary, resulting in a $4,850 foreign tax credit, which reduced our U.S. tax provision. In addition, we recorded a benefit in the first quarter of 2009 related to our 2008 tax year as a result of the reinstatement of the U.S. research and development tax credit under the TARP legislation.

Note 11 — Shareholders’ Equity

The changes in shareholders’ equity for the three months ended January 2, 2010 are summarized as follows:

						Number of Shares
						Class A				Class B
						Common				Common
		Amount				Stock				Stock
COMMON STOCK
Beginning and end of period		$	51,280				43,471,373				7,808,340
ADDITIONAL PAID-IN CAPITAL
Beginning of period			381,099				—				—
Equity-based compensation expense			2,784				—				—
Issuance of Treasury shares at more than cost			102				—				—
Income tax effect of equity-based compensation			11				—				—
Adjustment to market — SECT			334				—				—
End of period			384,330				—				—
RETAINED EARNINGS
Beginning of period			772,639				—				—
Net earnings			21,561				—				—
End of period			794,200				—				—
TREASURY STOCK
Beginning of period			(47,733	)			(2,303,699	)			(3,305,971	)
Issuance of treasury shares			315				59,062				—
Purchase of treasury shares			(334	)			(12,919	)			—
End of period			(47,752	)			(2,257,556	)			(3,305,971	)
STOCK EMPLOYEE COMPENSATION TRUST (SECT)
Beginning of period			(11,426	)			—				(398,552	)
Issuance of shares			1,071				—				39,844
Adjustment to market — SECT			(334	)			—				—
End of period			(10,689	)			—				(358,708	)
ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
Beginning of period			(80,826	)			—				—
Foreign currency translation adjustment			(1,426	)			—				—
Retirement liability adjustment			975				—				—
Decrease in accumulated loss on derivatives			766				—				—
End of period			(80,511	)			—				—
TOTAL SHAREHOLDERS’ EQUITY		$	1,090,858				41,213,817				4,143,661

Note 12 — Stock Employee Compensation Trust

The Stock Employee Compensation Trust (SECT) assists in administering and provides funding for equity-based compensation plans and benefit programs, including the Moog Inc. Retirement Savings Plan. The shares in the SECT are not considered outstanding for purposes of calculating earnings per share. However, in accordance with the trust agreement governing the SECT, the SECT trustee votes all shares held by the SECT on all matters submitted to shareholders.

Note 13 — Earnings per Share

Basic and diluted weighted-average shares outstanding are as follows:

		Three Months Ended
		January 2,				December 27,
		2010				2008
Weighted-average shares outstanding — Basic			45,323,349				42,607,289
Dilutive effect of equity-based awards			269,525				378,799
Weighted-average shares outstanding — Diluted			45,592,874				42,986,088
On October 2, 2009, we completed the offering and sale of 2,675,000 shares of Class A common stock at a price of $29.50 per share.
Note 14 — Comprehensive Income
The components of comprehensive income, net of tax, are as follows:
		Three Months Ended
		January 2,				December 27,
		2010				2008
Net earnings		$	21,561			$	30,270
Other comprehensive income (loss):
Foreign currency translation adjustment			(1,426	)			(20,570	)
Retirement liability adjustment, net of tax of $661 and $237, respectively			975				1,201
Decrease (increase) in accumulated loss on derivatives			766				(357	)
Comprehensive income		$	21,876			$	10,544
The components of accumulated other comprehensive (loss) income, net of tax, are as follows:
		January 2,				October 3,
		2010				2009
Cumulative foreign currency translation adjustment		$	42,296			$	43,722
Accumulated retirement liability adjustments			(123,384	)			(124,359	)
Accumulated gain (loss) on derivatives			577				(189	)
Accumulated other comprehensive (loss) income		$	(80,511	)		$	(80,826	)

Note 15 — Segment Information

Below are sales and operating profit by segment for the three months ended January 2, 2010 and December 27, 2008 and a reconciliation of segment operating profit to earnings before income taxes. Operating profit is net sales less cost of sales and other operating expenses, excluding interest expense, equity-based compensation expense and other corporate expenses. Cost of sales and other operating expenses are directly identifiable to the respective segment or allocated on the basis of sales, number of employees or profit.

		Three Months Ended
		January 2,				December 27,
		2010				2008
Net sales:
Aircraft Controls		$	175,060			$	163,149
Space and Defense Controls			69,491				71,382
Industrial Systems			136,352				110,035
Components			84,906				81,504
Medical Devices			29,369				20,018
Net sales		$	495,178			$	446,088
Operating profit (loss) and margins:
Aircraft Controls		$	17,610			$	13,500
			10.1	%			8.3	%
Space and Defense Controls			7,519				13,580
			10.8	%			19.0	%
Industrial Systems			11,181				11,499
			8.2	%			10.5	%
Components			12,122				15,001
			14.3	%			18.4	%
Medical Devices			139				(2,224	)
			0.5	%			(11.1	%)
Total operating profit			48,571				51,356
			9.8	%			11.5	%
Deductions from operating profit:
Interest expense			10,728				9,601
Equity-based compensation expense			2,784				2,589
Corporate expenses and other			5,607				2,793
Earnings before income taxes		$	29,452			$	36,373

Note 16 — Recent Accounting Pronouncements

In December 2007, the FASB issued new standards for business combinations as codified in Accounting Standards Codification (ASC) 805-10. The objective of the new standard is to improve the relevance, representational faithfulness and comparability of the information that a reporting entity provides in its financial reports about a business combination and its effects. It establishes principles and requirements for the acquirer to recognize and measure the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree, the goodwill acquired or a gain from a bargain purchase. It also provides disclosure requirements to enable users of the financial statements to evaluate the nature and financial effects of the business combination. The new standard applies prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. We have adopted this standard as of October 4, 2009.

In April 2009, the FASB issued new standards on identifiable assets and liabilities assumed in a business combination as codified in ASC 805-20. The new standard amends the provisions related to the initial recognition and measurement, subsequent measurement and disclosure of assets and liabilities arising from contingencies in a business combination. The new standard carries forward the requirements in current standards for acquired contingencies, thereby requiring that such contingencies be recognized at fair value on the acquisition date if fair value can be reasonably estimated during the allocation period. Otherwise, entities would typically account for the acquired contingencies in accordance with standards codified in ASC 450-10. The new standard is effective prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. We have adopted this standard as of October 4, 2009. The adoption of this standard did not have a material impact on our consolidated financial statements.

Note 17 — Subsequent Events

We have evaluated subsequent events through February 9, 2010, the date this report on Form 10-Q was filed with the U.S. Securities and Exchange Commission. We made no significant changes to our consolidated financial statements as a result of our subsequent events evaluation.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Company’s Form 10-K for the fiscal year ended October 3, 2009. All references to years in this Management’s Discussion and Analysis of Financial Condition and Results of Operations are to fiscal years.

OVERVIEW

We are a worldwide designer, manufacturer and integrator of high performance precision motion and fluid controls and control systems for a broad range of applications in aerospace and defense, industrial and medical markets. Our aerospace and defense products and systems include military and commercial aircraft flight controls, satellite positioning controls, controls for steering tactical and strategic missiles, thrust vector controls for space launch vehicles, controls for gun aiming, stabilization and automatic ammunition loading for armored combat vehicles, and homeland security products. Our industrial products are used in a wide range of applications, including injection molding machines, pilot training simulators, wind energy, power generation, material and automotive testing, metal forming, heavy industry and oil exploration. Our medical products include infusion therapy pumps, enteral clinical nutrition pumps, slip rings used on CT scanners and motors used in sleep apnea devices. We operate under five segments, Aircraft Controls, Space and Defense Controls, Industrial Systems, Components and Medical Devices. Our principal manufacturing facilities are located in the United States, including facilities in New York, California, Utah, Virginia, North Carolina, Pennsylvania, Ohio, Georgia and Illinois, and in England, Germany, Italy, Japan, the Philippines, Ireland, India and China.

We have long-term contracts with some of our customers. These contracts are predominantly within Aircraft Controls and Space and Defense Controls and represent approximately one-third of our sales. We recognize revenue on these contracts using the percentage of completion, cost-to-cost method of accounting as work progresses toward completion. The remainder of our sales are recognized when the risks and rewards of ownership and title to the product are transferred to the customer, principally as units are delivered or as service obligations are satisfied. This method of revenue recognition is predominantly used within the Industrial Systems, Components and Medical Devices segments, as well as with aftermarket activity.

We concentrate on providing our customers with products designed and manufactured to the highest quality standards. In achieving a leadership position in the high performance, precision controls market, we have capitalized on our strengths, which include:

	•		superior technical competence and customer intimacy breeding market leadership,
	•		customer diversity and broad product portfolio,
	•		well-established international presence serving customers worldwide, and
	•		proven ability to successfully integrate acquisitions.

We intend to increase our revenue base and improve our profitability and cash flows from operations by building on our market leadership positions, by strengthening our niche market positions in the principal markets that we serve and by extending our participation on the platforms we supply by providing more systems solutions. We also expect to maintain a balanced, diversified portfolio in terms of markets served, product applications, customer base and geographic presence. Our strategy to achieve our objectives includes:

	•		maintaining our technological excellence by building upon our systems integration capabilities while solving our customers’ most demanding technical problems,
	•		taking advantage of our global capabilities,
	•		growing our profitable aftermarket business,
	•		capitalizing on strategic acquisitions and opportunities,
	•		entering and developing new markets, and
	•		striving for continuing cost improvements.

Challenges facing us include adjusting to global economic conditions, improving shareholder value through increased profitability while experiencing pricing pressures from customers, strong competition and increases in costs such as health care benefits. We address these challenges by focusing on strategic revenue growth and by continuing to improve operating efficiencies through various process, manufacturing and restructuring initiatives and using low cost manufacturing facilities without compromising quality.

Acquisitions

All of our acquisitions are accounted for under the purchase method and, accordingly, the operating results for the acquired companies are included in the consolidated statements of earnings from the respective dates of acquisition. Under purchase accounting, we record assets and liabilities at fair value on the balance sheet. The purchase price described for each acquisition below is net of any cash acquired and includes debt issued or assumed.

In 2009, we completed eight business combinations within four of our segments. We completed two acquisitions in our Aircraft Controls segment, both of which are located in the U.K. for a total purchase price of $136 million. These acquisitions complement our flight control actuation business and expand our business in ground-based air navigation systems. We acquired one business in our Space and Defense Controls segment for $45 million that expands our capabilities in the security and surveillance markets. We completed three acquisitions in our Industrial Systems segment, two of which specialize in systems and blade controls of turbines for the wind energy market, for a total of $110 million, which includes $28 million for a 40% ownership paid in 2008 for one of the acquired companies. We also completed two acquisitions in our Medical Devices segment for a total purchase price of $36 million expanding our portfolio to include syringe style pumps, proprietary medical devices and contract manufacturing of disposables as well as microbiology, toxicology and sterilization services.

See the discussion in Note 2 of Item 1, Financial Statements of this report for further information on our acquisitions.

CRITICAL ACCOUNTING POLICIES

There have been no changes in critical accounting policies in the current year from those disclosed in our 2009 Form 10-K.

Reviews for Impairment of Goodwill

Our most recent test of goodwill for impairment was our annual test as of the beginning of our fourth quarter in 2009. The results of that test indicated that goodwill was not impaired. However, the fair value of our Aircraft Controls reporting unit was not significantly in excess of its carrying value. Its excess of fair value over carrying value was 6%. This reporting unit is one level below our Aircraft Controls segment and excludes the navigation aids business we acquired last year. This reporting unit had $104 million of goodwill allocated to it as of our most recent test.

The most significant assumptions in determining fair value are projected revenue growth rates, operating profit margins and cash flows, the terminal growth rate and the discount rate. Management projects revenue growth rates, operating margins and cash flows based on each reporting unit’s current business, expected developments and operational strategies over a five-year period. In estimating the terminal growth rate, we consider our historical and projected results, as well as the economic environment in which our reporting units operate. Significant program delays, changes in demand due to economic pressures or unfavorable terms in our contracts could have a negative effect on the fair value of this reporting unit.

RECENT ACCOUNTING PRONOUNCEMENTS

In September 2009, the FASB issued new standards for allocating revenue to multiple deliverables in a contract as codified in ASC 605-25. The new standard is effective for us at the beginning of 2011, with early adoption permitted. The new standard allows entities to allocate consideration in a multiple element arrangement in a manner that better reflects the transaction economics. When vendor specific objective evidence or third party evidence for deliverables in an arrangement cannot be determined, entities will be allowed to develop a best estimate of the selling price to separate deliverables and allocate arrangement consideration using the relative selling price method. Additionally, use of the residual method has been eliminated. We are currently evaluating the impact of adopting this standard on our consolidated financial statements.

See the discussion in Note 16 of Item 1, Financial Statements of this report for further information.

CONSOLIDATED RESULTS OF OPERATIONS AND OUTLOOK

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net sales		$	495.2			$	446.1
Gross margin			29.2	%			30.9	%
Research and development expenses		$	23.9			$	25.1
Selling, general and administrative expenses as a percentage of sales			15.8	%			15.5	%
Restructuring expense		$	1.8			$	—
Interest expense		$	10.7			$	9.6
Effective tax rate			26.8	%			16.8	%
Net earnings		$	21.6			$	30.3

Net sales increased $49 million, or 11%, in the first quarter of 2010 compared to the first quarter of 2009. Our sales were positively impacted by $81 million of incremental sales from recent acquisitions, partially offset by continued negative effects of the global recession, most significantly in our Industrial Systems segment.

Our gross margin was lower in the first quarter of 2010 compared to 2009, reflecting a less favorable product mix and lower sales volume excluding the effect of acquired businesses, offset by $6 million of reduced contract loss reserves additions.

Research and development expenses decreased $1 million in the first quarter of 2010 compared to the same period of 2009. The lower level of research and development expenses was primarily within Aircraft Controls as reduced expenses for the Boeing 787 and other Aircraft Controls programs have only been partially offset by increases for the Airbus A350 program.

Interest expense increased slightly in the first quarter of 2010 from the same period of 2009 as a result of higher debt levels being offset by lower average interest rates.

The effective tax rate for the first quarter of 2010 is lower than would be expected by applying the U.S. federal statutory tax rate to earnings before income taxes as a greater proportion of earnings came from foreign operations with lower tax rates. The effective tax rate for the first quarter of 2009 was low as a result of two items that occurred in the first quarter of 2009. We decided to repatriate approximately $31 million of cash back to the U.S. from our Japanese subsidiary. The average tax rate that has been paid in Japan exceeded our U.S. rate and, therefore, our repatriation decision resulted in a $5 million foreign tax credit, which reduced our U.S. tax provision. In addition, we recorded a $1.5 million benefit in the first quarter of 2009 related to our 2008 tax year as a result of the reinstatement of the U.S. research and development tax credit under TARP legislation.

Net earnings decreased 29% in the first quarter of 2010. Diluted earnings per share decreased 33% in the first quarter, reflecting additional outstanding shares as a result of a stock offering completed at the end of 2009.

2010 Outlook — We expect sales in 2010 to increase by 15% to approximately $2.12 billion reflecting increases in all of our segments, helped in part by recent acquisitions, especially in Industrial Systems and Aircraft Controls. We expect operating margins to be approximately 9.6% in 2010 compared to 9.3% in 2009. We expect operating margins to increase in Aircraft Controls, Industrial Systems and Medical Devices and decrease in Space and Defense Controls and Components. Restructuring costs are estimated to be $6 million in 2010 resulting from the continuation of staff reduction plans started in 2009. We expect net earnings to increase to $103 million and diluted earnings per share to increase by 14% to $2.25. Given the uncertainty in the global economy, these forecasted amounts are centered within a range of plus or minus $.10 per share.

SEGMENT RESULTS OF OPERATIONS AND OUTLOOK

Operating profit, as presented below, is net sales less cost of sales and other operating expenses, excluding interest expense, equity-based compensation expense and other corporate expenses. Cost of sales and other operating expenses are directly identifiable to the respective segment or allocated on the basis of sales, number of employees or profit. Operating profit is reconciled to earnings before income taxes in Note 15 of the Notes to Consolidated Condensed Financial Statements included in this report.

Aircraft Controls

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net sales — military aircraft		$	108.7			$	102.8
Net sales — commercial aircraft			57.3				57.5
Net sales — navigation aids			9.0				2.8
		$	175.0			$	163.1
Operating profit		$	17.6			$	13.5
Operating margin			10.1	%			8.3	%
Backlog		$	519.7			$	374.9

Net sales in Aircraft Controls increased $12 million, or 7%, in the first quarter of 2010. Military aircraft sales increased $6 million. Sales increased $11 million in military aftermarket and also increased due to the recent acquisition of the GE actuation business located in Wolverhampton, UK that contributed $10 million. Those increases more than offset a $9 million decrease on the F-35 program as we have begun to shift work from the development phase into the low-rate initial production phase. Commercial aircraft sales were relatively flat compared to the first quarter of 2009 as $11 million of sales from the Wolverhampton acquisition offset the decreases of $5 million in business jets and $4 million in aftermarket. Navigation aids increased $6 million as a result of incremental sales from the Fernau acquisition, which was completed in the second quarter of 2009.

Our operating margin was higher in the first quarter of 2010 compared to 2009 as a result of reduced contract loss reserve additions and lower research and development spending, partially offset by $1 million of restructuring charges incurred in 2010.

The higher level of twelve-month backlog for Aircraft Controls at January 2, 2010 compared to December 27, 2008 reflects the Wolverhampton and Fernau acquisitions along with strong military aircraft orders.

2010 Outlook for Aircraft Controls — We expect sales in Aircraft Controls to increase 12% to $742 million in 2010. Military aircraft sales are expected to increase 4% to $433 million as sales from Wolverhampton are expected to more than offset decreases in the F-35 program. Commercial aircraft sales are expected to increase 21% to $259 million, principally related to the Wolverhampton acquisition and increased sales to Boeing more than offsetting a decrease in business jets. Navigation aids are expected to increase to $50 million due in large part to the incremental sales from a full year of owning Fernau in addition to anticipated increased demand. We expect our operating margin to be 8.6% in 2010, an improvement from 7.9% in 2009, resulting from improved cost performance on various production programs.

Space and Defense Controls

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net sales		$	69.5			$	71.4
Operating profit		$	7.5			$	13.6
Operating margin			10.8	%			19.0	%
Backlog		$	201.6			$	153.8

Net sales in Space and Defense Controls decreased $2 million, or 3%, in the first quarter of 2010 compared to 2009. Sales of defense controls decreased $15 million as a result of strong sales on the Driver’s Vision Enhancer (DVE) program in the first quarter of 2009. Offsetting that decrease were increases in most of our other markets, including $5 million in homeland security as a result of our acquisition of Videolarm in the second quarter of 2009, $3 million in tactical missiles and $2 million in launch vehicles.

Our operating margin for Space and Defense Controls decreased significantly in the first quarter of 2010. The decrease resulted primarily from the strong volume and profitability on the DVE program in the first quarter of 2009.

The higher level of twelve-month backlog at January 2, 2010 compared to December 27, 2008 relates to increased orders for satellite programs, launch vehicles and tactical missiles.

2010 Outlook for Space and Defense Controls — We expect sales in Space and Defense Controls to increase $46 million, or 17%, to $320 million in 2010. We expect sales increases of $16 million in NASA programs, $13 million in tactical missiles, $10 million for homeland security and $10 million in launch vehicles. We expect our operating margin in 2010 to decrease to 10.2% from 14.6% in 2009, primarily as a result of a larger proportion of sales in 2010 coming from lower margin cost plus development work.

Industrial Systems

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net sales		$	136.4			$	110.0
Operating profit		$	11.2			$	11.5
Operating margin			8.2	%			10.5	%
Backlog		$	190.2			$	149.2

Net sales in Industrial Systems increased $26 million, or 24%, in the first quarter of 2010 compared to 2009. The acquisitions of LTi REEnergy and Insensys accounted for $45 million of sales in the wind energy market. Offsetting the incremental sales from these acquisitions were lower sales in many of our major markets as a result of the global recession. Sales in the motion simulation business were down $6 million, power generation declined $3 million and sales for controls for metal forming presses decreased $3 million, reflecting the continuing effects of the global recession that first started to affect our industrial business in the second quarter of 2009.

Our operating margin for Industrial Systems decreased in the first quarter of 2010 over the comparable 2009 period. The decrease is a result of the lower sales volume in 2010, excluding the effects of the acquired companies, as well as $2 million of equity earnings recorded in 2009 for our 40% ownership of LTi REEnergy.

The higher level of twelve-month backlog for Industrial Systems at January 2, 2010 compared to December 27, 2008 primarily relates to the backlog from acquired companies, partially offset by lower demand in most of our other major markets due to the global recession.

2010 Outlook for Industrial Systems — We expect sales in Industrial Systems to increase 26% to $573 million in 2010. We expect sales to increase $121 million for wind energy as a result of the LTi REEnergy and Insensys acquisitions. Sales excluding the effects of acquired businesses will be relatively flat compared to the prior year. We expect sales increases in test equipment and plastics making machinery to be offset by declines in power generation, heavy industry and motion simulator business. We expect our operating margin to increase to 8.6% in 2010 from 6.8% in 2009. The expected increase in our operating margin will reflect lower restructuring charges and higher sales volume.

Components

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net sales		$	84.9			$	81.5
Operating profit		$	12.1			$	15.0
Operating margin			14.3	%			18.4	%
Backlog		$	176.3			$	188.5

Net sales in Components increased $3 million, or 4%, in the first quarter of 2010 compared to 2009. Sales increased in the aircraft and space and defense markets but declined in our other markets. Aircraft sales increased $5 million across multiple programs, including fiber optic controls on the Eurofighter, the Guardian program and systems for the Black Hawk helicopter and V-22 tilt rotor aircraft. Sales of space and defense controls increased $5 million, primarily driven by a new contract for a slip ring system on the Common Remotely Operated Weapons Station (CROWS) system. Marine sales decreased $3 million, mostly for equipment used on undersea robots as demand has declined in relation to the price of oil. Total medical sales decreased $2 million and industrial sales decreased $1 million, largely from recessionary pressures.

Our operating margin decreased in the first quarter of 2010 compared to 2009 as a result of the sales mix shift toward more aircraft and space and defense sales and away from industrial and marine products.

The lower level of twelve-month backlog at January 2, 2010 compared to December 27, 2008 primarily relates to slowing orders for marine products.

2010 Outlook for Components — We expect sales in Components to increase slightly to $356 million in 2010. We expect sales increases of $20 million in aircraft, which is primarily driven by the Guardian program, and $13 million from industrial markets, primarily from slip rings for wind turbines. Sales in the medical market will remain flat and we expect sales decreases within space and defense controls and the marine market. We expect our operating margin in 2010 to be 15.1% in 2010, slightly lower than the 16.1% we achieved in 2009 due to the sales mix.

Medical Devices

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net sales		$	29.4			$	20.0
Operating profit (loss)		$	0.1			$	(2.2	)
Operating margin			0.5	%			(11.1	)%
Backlog		$	10.1			$	11.4

Net sales in Medical Devices increased $9 million, or 47%, in the first quarter of 2010 compared to 2009. Incremental sales from the Aitecs and Ethox acquisitions in the second quarter of 2009 provided $6 million of the increase. Sales for intravenous, enteral and disposable pumps increased $1 million, or 20%, and sales of administration sets also increased $1 million, or 16%.

Our operating margin increased in the first quarter of 2010 relative to 2009 as a result of the higher sales volume in 2010 and a $1 million reserve established for a voluntary software modification for certain of our enteral feeding pumps in 2009, partially offset by start up costs for a new low cost production facility.

Twelve-month backlog for Medical Devices is not as substantial relative to sales as in our other segments, reflecting the shorter order-to-shipment cycle for this line of business.

2010 Outlook for Medical Devices — We expect sales in Medical Devices to increase $18 million, or 16%, to $129 million in 2010. We expect sales increases partly due to a broader product offering, including increases of $6 million in pumps and $5 million in administration sets. In addition, we expect $5 million of incremental sales from a full year of owning Aitecs and Ethox. We expect our operating margin to be 3.5% as a result of the sales volume increases and cost improvements expected in the latter half of the year.

FINANCIAL CONDITION AND LIQUIDITY

		Three Months Ended
		January 2,				December 27,
(dollars in millions)		2010				2008
Net cash provided (used) by:
Operating activities		$	56.1			$	32.5
Investing activities			(12.0	)			(34.5	)
Financing activities			(23.8	)			36.1

Our available borrowing capacity and our cash flow from operations provide us with the financial resources needed to run our operations, reinvest in our business and make strategic acquisitions.

Operating activities

Net cash provided by operating activities increased in the first quarter of 2010 compared to 2009. The increase relates primarily to lower inventory levels in 2010.

Investing activities

Net cash used by investing activities in the first three months of 2010 includes $12 million for capital expenditures. Net cash used by investing activities in the first three months of 2009 consisted principally of $20 million of capital expenditures and $14 million for the acquisition of Berkeley Process Controls.

Our capital expenditures in 2010 will approximate $75 million.

Financing activities

Net cash used by financing activities in the first three months of 2010 reflects pay downs on our U.S. credit facility. Net cash provided by financing activities in the first three months of 2009 reflects borrowings on our U.S. credit facility for acquisitions, operations and $7 million used for our share repurchase program.

Off Balance Sheet Arrangements

We do not have any material off balance sheet arrangements that have or are reasonably likely to have a material future effect on our results of operations or financial condition.

Contractual Obligations and Commercial Commitments

Our contractual obligations and commercial commitments have not changed materially from the disclosures in our 2009 Form 10-K.

CAPITAL STRUCTURE AND RESOURCES

We maintain bank credit facilities to fund our short and long-term capital requirements, including for acquisitions. From time to time, we also sell equity and debt securities to fund acquisitions or take advantage of favorable market conditions.

Our largest credit facility is our U.S. credit facility, which matures on March 14, 2013. It consists of a $750 million revolver and had an outstanding balance of $397 million at January 2, 2010. Interest on the majority of the outstanding credit facility borrowings is based on LIBOR plus the applicable margin, which was 225 basis points at January 2, 2010 and will decrease to 200 basis points during the second quarter of 2010. The credit facility is secured by substantially all of our U.S. assets.

The U.S. credit facility contains various covenants. The covenant for minimum net worth, defined as total shareholders’ equity adjusted to maintain the amounts of accumulated other comprehensive loss at the level in existence as of September 30, 2006, is $600 million. The covenant for minimum interest coverage ratio, defined as the ratio of EBITDA to interest expense for the most recent four quarters, is 3.0. The covenant for the maximum leverage ratio, defined as the ratio of net debt, including letters of credit, to EBITDA for the most recent four quarters, is 4.0. The covenant for maximum senior leverage ratio, defined as the ratio of net senior debt to consolidated EBITDA for the most recent four quarters is 2.75. The covenant for maximum capital expenditures is $100 million annually. We are in compliance with all covenants. EBITDA is defined in the loan agreement as (i) the sum of net income, interest expense, income taxes, depreciation expense, amortization expense, other non-cash items reducing consolidated net income and non-cash equity-based compensation expenses minus (ii) other non-cash items increasing consolidated net income. The definition of EBITDA allows for the exclusion of up to $17 million of restructuring charges incurred in calendar year 2009.

We are required to obtain the consent of lenders of the U.S. credit facility before raising significant additional debt financing. In recent years, we have demonstrated our ability to secure consents to access debt markets. We have also been successful in accessing equity markets, as demonstrated most recently by our October 2, 2009 sale of 2,675,000 shares of Class A common stock at $29.50 per share. We believe that we will be able to obtain additional debt or equity financing as needed.

At January 2, 2010, we had $381 million of unused borrowing capacity, including $343 million from the U.S. credit facility after considering standby letters of credit. Our ability to utilize the unused borrowing capacity is limited by the maximum leverage ratio covenant, which would restrict borrowings to an additional $325 million as of January 2, 2010.

Net debt to capitalization was 39% at January 2, 2010 and 41% at October 3, 2009. The decrease in net debt to capitalization is primarily due to our positive cash flow and net earnings in the first quarter of 2010.

We believe that our cash on hand, cash flows from operations and available borrowings under short and long-term lines of credit will continue to be sufficient to meet our operating needs.

ECONOMIC CONDITIONS AND MARKET TRENDS

We operate within the aerospace and defense, industrial and medical markets. Our aerospace and defense markets are affected by market conditions and program funding levels, while our industrial markets are influenced by general capital investment trends. Our medical markets are influenced by economic conditions, population demographics, medical advances and patient demand. A common factor throughout our markets is the continuing demand for technologically advanced products.

Aerospace and Defense

Approximately 62% of our 2009 sales were generated in aerospace and defense markets. The military aircraft market is dependent on military spending for development and production programs. Production programs are typically long-term in nature, offering predictability as to capacity needs and future revenues. We maintain positions on numerous high priority programs, including the F-35 Joint Strike Fighter, F/A-18E/F Super Hornet and V-22 Osprey. The large installed base of our products leads to attractive aftermarket sales and service opportunities. Aftermarket revenues are expected to continue to grow due to a number of scheduled military retrofit programs and increased flight hours resulting from increased military commitments.

The commercial OEM market has historically exhibited cyclical swings and sensitivity to economic conditions. The aftermarket is driven by usage of the existing aircraft fleet, the age of the installed fleet and is currently being impacted by fleet re-sizing programs for passenger and cargo aircraft. Changes in aircraft utilization rates affect the need for maintenance and spare parts and impact aftermarket sales. Boeing and Airbus have historically adjusted production in line with air traffic volume.

The military and government space market is primarily dependent on the authorized levels of funding for satellite communications. Government spending on military satellites has risen in recent years as the military’s need for improved intelligence gathering has increased. The commercial space market is comprised of large satellite customers, traditionally telecommunications companies. Trends for this market, as well as for commercial launch vehicles, follow the telecommunications companies’ need for increased capacity and the satellite replacement lifecycle of 7-10 years. Our position as a legacy supplier of steering and fuel controls to NASA on a variety of programs over the past decades, including the Constellation program, positions us to take advantage of opportunities regardless of the direction that Congress and the Administration decide.

The tactical missile, missile defense and defense controls markets are dependent on many of the same market conditions as military aircraft, including overall military spending and program funding levels. Our homeland security product line is dependent on government funding at federal and local levels, as well as private sector demand.

Industrial

Approximately 29% of our 2009 sales were generated in industrial markets. The industrial markets we serve are influenced by several factors, including capital investment, product innovation, economic growth, cost-reduction efforts and technology upgrades. We are experiencing challenges from current global economic conditions. These challenges include reacting to slowing demand for industrial automation equipment, steel and automotive manufacturing and delayed orders as customers manage inventory levels. Despite the general slowdown in demand from the global recession, we continue to see strong demand in the growing wind energy market.

Medical

Approximately 9% of our 2009 sales were generated in medical markets. The medical markets we serve are influenced by economic conditions, hospital and outpatient clinic spending on equipment, population demographics, medical advances, patient demands and the need for precision control components and systems. Advances in medical technology and medical treatments have had the effect of extending the average life span, in turn resulting in greater need for medical services. These same technology and treatment advances also drive increased demand from the general population as a means to improve quality of life. Greater access to medical insurance, whether through government funded health care plans or private insurance, also increases the demand for medical services.

Foreign Currencies

We are affected by the movement of foreign currencies compared to the U.S. dollar, particularly in Industrial Systems. About one-quarter of our 2009 sales were denominated in foreign currencies including the euro, British pound and Japanese yen. During the first three months of 2010, foreign currencies generally strengthened against the U.S. dollar and the translation of the results of our foreign subsidiaries into U.S. dollars increased sales by $8 million compared to the same period one year ago. During 2009, foreign currencies generally weakened against the U.S. dollar and the translation of the results of our foreign subsidiaries into U.S. dollars decreased sales by $49 million compared to 2008.

Cautionary Statement

Information included or incorporated by reference in this report that does not consist of historical facts, including statements accompanied by or containing words such as “may,” “will,” “should,” “believes,” “expects,” “expected,” “intends,” “plans,” “projects,” “approximate,” “estimates,” “predicts,” “potential,” “outlook,” “forecast,” “anticipates,” “presume” and “assume,” are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and are subject to several factors, risks and uncertainties, the impact or occurrence of which could cause actual results to differ materially from the expected results described in the forward-looking statements. These important factors, risks and uncertainties include:

	•		fluctuations in general business cycles for commercial aircraft, military aircraft, space and defense products, industrial capital goods and medical devices;
	•		our dependence on government contracts that may not be fully funded or may be terminated;
	•		our dependence on certain major customers, such as The Boeing Company and Lockheed Martin, for a significant percentage of our sales;
	•		delays by our customers in the timing of introducing new products, which may affect our earnings and cash flow;
	•		the possibility that the demand for our products may be reduced if we are unable to adapt to technological change;
	•		intense competition, which may require us to lower prices or offer more favorable terms of sale;
	•		our indebtedness, which could limit our operational and financial flexibility;
	•		the possibility that new product and research and development efforts may not be successful, which could reduce our sales and profits;
	•		increased cash funding requirements for pension plans, which could occur in future years based on assumptions used for our defined benefit pension plans, including returns on plan assets and discount rates;
	•		a write-off of all or part of our goodwill or intangible assets, which could adversely affect our operating results and net worth and cause us to violate covenants in our bank agreements;
	•		the potential for substantial fines and penalties or suspension or debarment from future contracts in the event we do not comply with regulations relating to defense industry contracting;
	•		the potential for cost overruns on development jobs and fixed-price contracts and the risk that actual results may differ from estimates used in contract accounting;
	•		the possibility that our subcontractors may fail to perform their contractual obligations, which may adversely affect our contract performance and our ability to obtain future business;
	•		our ability to successfully identify and consummate acquisitions, and integrate the acquired businesses and the risks associated with acquisitions, including that the acquired businesses do not perform in accordance with our expectations, and that we assume unknown liabilities in connection with acquired businesses for which we are not indemnified;
	•		our dependence on our management team and key personnel;
	•		the possibility of a catastrophic loss of one or more of our manufacturing facilities;
	•		the possibility that future terror attacks, war or other civil disturbances could negatively impact our business;
	•		that our operations in foreign countries could expose us to political risks and adverse changes in local, legal, tax and regulatory schemes;
	•		the possibility that government regulation could limit our ability to sell our products outside the United States;
	•		product quality or patient safety issues with respect to our medical devices business that could lead to product recalls, withdrawal from certain markets, delays in the introduction of new products, sanctions, litigation, declining sales or actions of regulatory bodies and government authorities;
	•		the impact of product liability claims related to our products used in applications where failure can result in significant property damage, injury or death and in damage to our reputation;
	•		changes in medical reimbursement rates of insurers to medical service providers, which could affect sales of our medical products;
	•		the possibility that litigation results may be unfavorable to us;
	•		our ability to adequately enforce our intellectual property rights and the possibility that third parties will assert intellectual property rights that prevent or restrict our ability to manufacture, sell, distribute or use our products or technology;
	•		foreign currency fluctuations in those countries in which we do business and other risks associated with international operations;
	•		the cost of compliance with environmental laws;
	•		the risk of losses resulting from maintaining significant amounts of cash and cash equivalents at financial institutions that are in excess of amounts insured by governments;
	•		the inability to modify, to refinance or to utilize amounts presently available to us under our credit facilities given uncertainties in the credit markets;
	•		our ability to meet the restrictive covenants under our credit facilities since a breach of any of these covenants could result in a default under our credit agreements; and
	•		our customers’ inability to continue operations or to pay us due to adverse economic conditions or their inability to access available credit.

These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. Given these factors, risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictive of future results. We disclaim any obligation to update the forward-looking statements made in this report.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Refer to the Company’s Annual Report on Form 10-K for the year ended October 3, 2009 for a complete discussion of our market risk. There have been no material changes in the current year regarding this market risk information.

Item 4. Controls and Procedures.

(a)		Disclosure Controls and Procedures. Moog carried out an evaluation, under the supervision and with the participation of Company management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures are effective as of the end of the period covered by this report, to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, and that such information is accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.
(b)		Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(c) The following table summarizes our purchases of our common stock for the quarter ended January 2, 2010.

														(d) Maximum
										(c) Total				Number (or
										Number of				Approximate
										Shares				Dollar Value) of
										Purchased as				Shares that May
										Part of Publicly				yet be
		(a) Total Number				(b) Average				Announced				Purchased
		of Shares				Price Paid Per				Plans or				Under the Plans
Period		Purchased (1)				Share				Programs (2)				or Programs(2)
October 4 - October 31, 2009			—			$	—				—				766,400
November 1 - 30, 2009			12,919			$	25.86				—				766,400
December 1, 2009 - January 2, 2010			—			$	—				—				766,400
Total			12,919			$	25.86				—				766,400

Item 6. Exhibits

(a)		Exhibits
			31.1			Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			31.2			Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			32.1			Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Exhibit Index

Exhibits
Description
31.1		Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.